Sleep Specialists LLC, developers of the US Food and Drug Administration-cleared Zzoma positional therapy device, and ISD Health Solutions, a provider of sleep disorder treatment in the Caribbean, have partnered to bring Zzoma to patients with mild to moderate positional obstructive sleep apnea. 

This partnership aligns with Sleep Specialists’ global strategy to educate physicians and patients that Zzoma can benefit almost two-thirds of all obstructive sleep apnea patients, according to a release from Sleep Specialists.

ISD Health Solutions, which addresses the high rates of diabetes and obesity linked to sleep apnea in Trinidad and Tobago and the broader Caribbean region, will now incorporate Zzoma into its clinical services.

“We are excited to partner with ISD Health Solutions,” says Michael J. Markus, PhD, executive director of Sleep Specialists LLC, in a release. “Their dedication to improving sleep health aligns perfectly with our mission to provide innovative and accessible treatment options for sleep apnea.”

According to Sleep Specialists, potential benefits of Zzoma positional therapy are:

  • Expanded treatment options: Zzoma is an alternative or supplement to CPAP therapy, especially for those diagnosed with positional obstructive sleep apnea.
  • Increased patient compliance: Zzoma’s comfort and ease of use may lead to better patient adherence, potentially translating into positive health outcomes.

ISD Health Solutions will provide Zzoma in conjunction with diagnostic sleep testing, consumer education, and other sleep disorder treatments. Services are covered by most regional insurance providers.

“Zzoma offers a unique solution that has the potential to significantly impact the lives of countless patients in the Caribbean,” says Gregory Arneaud, clinical director of ISD Health Solutions, in a release. “By adding Zzoma to our treatment offerings, we can help more people find relief and improve their overall health and well-being.”